TSX:MDNA - Post Discussion
Post by
HarryGluten on Nov 17, 2021 6:45am
mdna 55 deal
This would be huge:
Resesarch Capital Analyst Uddin believes efforts to secure deal for $MDNA 55 prior to start of Phase 3 clinical trial will serve as key catalyst, as he made the assumption of a potential deal in the opening quarter of 2022 calendar year with $60 mm in cash upfront mnda price target $6.90
Be the first to comment on this post